Overview

Efficacy of Pregabalin in Migraine Prevention

Status:
Withdrawn
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of pregabalin in comparison with sodium valproate in migraine prevention with a randomized blinded crossover study.
Phase:
Phase 3
Details
Lead Sponsor:
Hospital Militar del General Luis Felipe Brieba Aran
Treatments:
Pregabalin
Valproic Acid